NPI Details
Ethan Samuel Winer Ben-sorek, M.D. is an internal medicine in New Hyde Park, NY with 37 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Ethan Samuel Winer Ben-sorek, M.D. NPI is 1609878305. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
The provider's business location address is:
1 DAKOTA DR STE 205
NEW HYDE PARK, NY
ZIP 11042-136
Phone: (516) 622-6020
Fax: (516) 622-6021
The NPI 1609878305 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Blood test, comprehensive group of blood chemicals (HCPCS:80053)
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
- Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
- Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
- Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
- Advance care planning, first 30 minutes (HCPCS:99497)
- Annual depression screening, 15 minutes (HCPCS:G0444)
- Vitamin d-3 level (HCPCS:82306)
- Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
- Automated urinalysis test (HCPCS:81003)
- Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
- Hemoglobin a1c level (HCPCS:83036)
- Psa (prostate specific antigen) measurement, total (HCPCS:84153)
- Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
- Urine microalbumin (protein) level (HCPCS:82043)
- Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
- Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
- Administration of influenza virus vaccine (HCPCS:G0008)
- Influenza vaccine split virus, preservative free (HCPCS:90662)
- Ferritin (blood protein) level (HCPCS:82728)
- Iron level (HCPCS:83540)
- Iron binding capacity (HCPCS:83550)
- Thyroxine (thyroid chemical), free (HCPCS:84439)
- Folic acid level, serum (HCPCS:82746)
- Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
- Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
- Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
- Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
- Magnesium level (HCPCS:83735)
- Uric acid level, blood (HCPCS:84550)
- Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
The enumeration date for this NPI number is 8/11/2005 and was last updated on 6/8/2020.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207R00000X | Internal Medicine | | 183765 | NEW YORK | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 183765 | OTHER | NEW YORK | LICENSE |
